Brief: Nykode Therapeutics: Issuance Of Key Patent Covering Individualized Neoantigen Based Vaccines
Aug 14 (Reuters) - Nykode Therapeutics ASA NYKD.OL :
* NYKODE THERAPEUTICS ANNOUNCES ISSUANCE OF KEY PATENT
COVERING
INDIVIDUALIZED NEOANTIGEN BASED VACCINES
* 20 YEAR EXPIRATION DATE OF THIS PATENT IS JANUARY 5, 2037
* UNITED STATES PATENT AND TRADEMARK OFFICE (USPTO) HAS
ISSUED
U.S. PATENT NO. 12,059,459
Source text for Eikon: ID:nObiTRZz6a
Further company coverage: NYKD.OL
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Nykode Therapeutics ASA
See all newsRCS - Accession Theraptcs. - Accession Therapeutics: Board appointments
Brief: Nykode Therapeutics Mulls Private Placement
Brief: Nykode Receives Draft Recommendation In Tax Case
Brief: Nykode Therapeutics Receives U.S. Vaccine Patent
Brief: Nykode Therapeutics Expects Draft Recommendation From Norwegian Tax Appeal Board In August 2026